vs
CoStar Group（CSGP）与礼蓝动物保健（ELAN）财务数据对比。点击上方公司名可切换其他公司
礼蓝动物保健的季度营收约是CoStar Group的1.3倍（$1.1B vs $899.9M），CoStar Group净利率更高（5.2% vs -24.1%，领先29.3%），CoStar Group同比增速更快（26.9% vs 12.2%），CoStar Group自由现金流更多（$101.3M vs $46.0M），过去两年CoStar Group的营收复合增速更高（17.1% vs -2.6%）
CoStar Group是1987年成立的美国商业地产服务商，总部位于弗吉尼亚州阿灵顿，业务覆盖北美、欧洲地区，为商业地产行业提供信息、分析及营销解决方案，旗下运营CoStar线上数据库、新闻网站及Apartments.com、Homes.com等多个线上平台。
礼蓝动物保健是一家美国动物保健制药企业，专注于生产宠物及家畜用药品与疫苗。该公司原为礼来公司旗下子公司，2019年完成分拆独立，目前是全球第三大动物保健企业。
CSGP vs ELAN — 直观对比
营收规模更大
ELAN
是对方的1.3倍
$899.9M
营收增速更快
CSGP
高出14.7%
12.2%
净利率更高
CSGP
高出29.3%
-24.1%
自由现金流更多
CSGP
多$55.3M
$46.0M
两年增速更快
CSGP
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $899.9M | $1.1B |
| 净利润 | $46.5M | $-276.0M |
| 毛利率 | 78.6% | 51.5% |
| 营业利润率 | 5.5% | -22.6% |
| 净利率 | 5.2% | -24.1% |
| 营收同比 | 26.9% | 12.2% |
| 净利润同比 | -22.2% | -3350.0% |
| 每股收益（稀释后） | $0.12 | $-0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSGPELAN
| Q4 25 | $899.9M | $1.1B | ||
| Q3 25 | $833.6M | $1.1B | ||
| Q2 25 | $781.3M | $1.2B | ||
| Q1 25 | $732.2M | $1.2B | ||
| Q4 24 | $709.4M | $1.0B | ||
| Q3 24 | $692.6M | $1.0B | ||
| Q2 24 | $677.8M | $1.2B | ||
| Q1 24 | $656.4M | $1.2B |
净利润CSGPELAN
| Q4 25 | $46.5M | $-276.0M | ||
| Q3 25 | $-30.9M | $-34.0M | ||
| Q2 25 | $6.2M | $11.0M | ||
| Q1 25 | $-14.8M | $67.0M | ||
| Q4 24 | $59.8M | $-8.0M | ||
| Q3 24 | $53.0M | $364.0M | ||
| Q2 24 | $19.2M | $-50.0M | ||
| Q1 24 | $6.7M | $32.0M |
毛利率CSGPELAN
| Q4 25 | 78.6% | 51.5% | ||
| Q3 25 | 79.3% | 53.4% | ||
| Q2 25 | 78.5% | 57.5% | ||
| Q1 25 | 79.1% | 57.3% | ||
| Q4 24 | 80.1% | 50.9% | ||
| Q3 24 | 79.7% | 52.2% | ||
| Q2 24 | 80.0% | 58.2% | ||
| Q1 24 | 78.5% | 57.3% |
营业利润率CSGPELAN
| Q4 25 | 5.5% | -22.6% | ||
| Q3 25 | -6.1% | -4.4% | ||
| Q2 25 | -3.5% | 2.0% | ||
| Q1 25 | -5.8% | 5.0% | ||
| Q4 24 | 5.6% | -5.0% | ||
| Q3 24 | 3.4% | 54.3% | ||
| Q2 24 | -2.4% | -2.7% | ||
| Q1 24 | -6.5% | 1.0% |
净利率CSGPELAN
| Q4 25 | 5.2% | -24.1% | ||
| Q3 25 | -3.7% | -3.0% | ||
| Q2 25 | 0.8% | 0.9% | ||
| Q1 25 | -2.0% | 5.6% | ||
| Q4 24 | 8.4% | -0.8% | ||
| Q3 24 | 7.7% | 35.3% | ||
| Q2 24 | 2.8% | -4.2% | ||
| Q1 24 | 1.0% | 2.7% |
每股收益（稀释后）CSGPELAN
| Q4 25 | $0.12 | $-0.55 | ||
| Q3 25 | $-0.07 | $-0.07 | ||
| Q2 25 | $0.01 | $0.02 | ||
| Q1 25 | $-0.04 | $0.13 | ||
| Q4 24 | $0.14 | $-0.01 | ||
| Q3 24 | $0.13 | $0.73 | ||
| Q2 24 | $0.05 | $-0.10 | ||
| Q1 24 | $0.02 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6B | $545.0M |
| 总债务越低越好 | $140.0M | $3.9B |
| 股东权益账面价值 | $8.3B | $6.5B |
| 总资产 | $10.5B | $13.4B |
| 负债/权益比越低杠杆越低 | 0.02× | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资CSGPELAN
| Q4 25 | $1.6B | $545.0M | ||
| Q3 25 | $1.9B | $505.0M | ||
| Q2 25 | $3.6B | $539.0M | ||
| Q1 25 | $3.7B | $487.0M | ||
| Q4 24 | $4.7B | $468.0M | ||
| Q3 24 | — | $490.0M | ||
| Q2 24 | — | $416.0M | ||
| Q1 24 | — | $345.0M |
总债务CSGPELAN
| Q4 25 | $140.0M | $3.9B | ||
| Q3 25 | $1.0B | $4.0B | ||
| Q2 25 | $1.0B | $4.1B | ||
| Q1 25 | $1.0B | $4.4B | ||
| Q4 24 | $1.0B | $4.3B | ||
| Q3 24 | $1.0B | $4.4B | ||
| Q2 24 | $1.0B | $5.7B | ||
| Q1 24 | $1.0B | $5.8B |
股东权益CSGPELAN
| Q4 25 | $8.3B | $6.5B | ||
| Q3 25 | $8.6B | $6.7B | ||
| Q2 25 | $8.6B | $6.8B | ||
| Q1 25 | $8.6B | $6.4B | ||
| Q4 24 | $7.6B | $6.1B | ||
| Q3 24 | $7.5B | $6.5B | ||
| Q2 24 | $7.4B | $5.9B | ||
| Q1 24 | $7.3B | $6.1B |
总资产CSGPELAN
| Q4 25 | $10.5B | $13.4B | ||
| Q3 25 | $10.8B | $13.6B | ||
| Q2 25 | $10.5B | $13.7B | ||
| Q1 25 | $10.4B | $12.9B | ||
| Q4 24 | $9.3B | $12.6B | ||
| Q3 24 | $9.1B | $13.3B | ||
| Q2 24 | $9.1B | $13.8B | ||
| Q1 24 | $9.0B | $14.0B |
负债/权益比CSGPELAN
| Q4 25 | 0.02× | 0.60× | ||
| Q3 25 | 0.12× | 0.59× | ||
| Q2 25 | 0.12× | 0.61× | ||
| Q1 25 | 0.12× | 0.69× | ||
| Q4 24 | 0.13× | 0.70× | ||
| Q3 24 | 0.13× | 0.67× | ||
| Q2 24 | 0.14× | 0.96× | ||
| Q1 24 | 0.14× | 0.95× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $162.1M | $108.0M |
| 自由现金流经营现金流 - 资本支出 | $101.3M | $46.0M |
| 自由现金流率自由现金流/营收 | 11.3% | 4.0% |
| 资本支出强度资本支出/营收 | 6.8% | 5.4% |
| 现金转化率经营现金流/净利润 | 3.49× | — |
| 过去12个月自由现金流最近4个季度 | $123.0M | $284.0M |
8季度趋势，按日历期对齐
经营现金流CSGPELAN
| Q4 25 | $162.1M | $108.0M | ||
| Q3 25 | $68.2M | $219.0M | ||
| Q2 25 | $146.5M | $237.0M | ||
| Q1 25 | $53.2M | $-4.0M | ||
| Q4 24 | $94.6M | $177.0M | ||
| Q3 24 | $100.3M | $162.0M | ||
| Q2 24 | $58.1M | $200.0M | ||
| Q1 24 | $139.6M | $2.0M |
自由现金流CSGPELAN
| Q4 25 | $101.3M | $46.0M | ||
| Q3 25 | $-5.5M | $127.0M | ||
| Q2 25 | $27.7M | $180.0M | ||
| Q1 25 | $-500.0K | $-69.0M | ||
| Q4 24 | $25.2M | $130.0M | ||
| Q3 24 | $40.2M | $120.0M | ||
| Q2 24 | $-14.7M | $166.0M | ||
| Q1 24 | $-237.1M | $-22.0M |
自由现金流率CSGPELAN
| Q4 25 | 11.3% | 4.0% | ||
| Q3 25 | -0.7% | 11.2% | ||
| Q2 25 | 3.5% | 14.5% | ||
| Q1 25 | -0.1% | -5.8% | ||
| Q4 24 | 3.6% | 12.7% | ||
| Q3 24 | 5.8% | 11.7% | ||
| Q2 24 | -2.2% | 14.0% | ||
| Q1 24 | -36.1% | -1.8% |
资本支出强度CSGPELAN
| Q4 25 | 6.8% | 5.4% | ||
| Q3 25 | 8.8% | 8.1% | ||
| Q2 25 | 15.2% | 4.6% | ||
| Q1 25 | 7.3% | 5.4% | ||
| Q4 24 | 9.8% | 4.6% | ||
| Q3 24 | 8.7% | 4.1% | ||
| Q2 24 | 10.7% | 2.9% | ||
| Q1 24 | 57.4% | 2.0% |
现金转化率CSGPELAN
| Q4 25 | 3.49× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 23.63× | 21.55× | ||
| Q1 25 | — | -0.06× | ||
| Q4 24 | 1.58× | — | ||
| Q3 24 | 1.89× | 0.45× | ||
| Q2 24 | 3.03× | — | ||
| Q1 24 | 20.84× | 0.06× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSGP
| Co Star | $503.8M | 56% |
| Other | $283.0M | 31% |
| Loop Net | $94.7M | 11% |
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
